Table of Contents
इक्विटी फंड असे आहेत ज्यांचे फंड पैसे विविध कंपन्यांच्या इक्विटी आणि इक्विटी-संबंधित साधनांमध्ये गुंतवले जातात. इक्विटी फंडांना मध्यम आणि उच्च- अशा लोकांसाठी दीर्घकालीन गुंतवणूकीचा पर्याय मानला जातो.धोका भूक. इक्विटी फंडांच्या विविध श्रेणींमध्ये या गोष्टींचा समावेश आहेलार्ज कॅप फंड,मिड कॅप फंड,स्मॉल कॅप फंड,ELSS, इत्यादी. वर्ष 2019 मध्ये इक्विटी मार्केटमध्ये तेजीची नोंद झाली आहे ज्यामुळे बहुतांश इक्विटी फंडाच्या श्रेणींनी चांगली कामगिरी केली आहे. या फंडांची कार्यक्षमता उद्योगाची कामगिरी, कंपनीची कामगिरी, कंपन्यांची मिळकत आणि नफा, त्यातील भविष्यातील संभाव्यता इत्यादी बर्याच मॅक्रो आणि मायक्रो इकॉनॉमिक पॅरामीटर्सवर अवलंबून असते. शीर्ष आणिबेस्ट इक्विटी फंड सन २०१ 2019 साठी खालीलप्रमाणे आहे.
Talk to our investment specialist
Fund NAV Net Assets (Cr) 2023 (%) 2022 (%) 2021 (%) 2020 (%) 2019 (%) Motilal Oswal Midcap 30 Fund Growth ₹93.2566
↑ 0.75 ₹24,488 57.1 41.7 10.7 55.8 9.3 LIC MF Infrastructure Fund Growth ₹41.4695
↑ 0.80 ₹881 47.8 44.4 7.9 46.6 -0.1 Motilal Oswal Long Term Equity Fund Growth ₹44.2801
↑ 0.71 ₹3,876 47.7 37 1.8 32.1 8.8 Motilal Oswal Multicap 35 Fund Growth ₹55.388
↑ 0.52 ₹11,855 45.7 31 -3 15.3 10.3 Invesco India Mid Cap Fund Growth ₹149.7
↑ 2.29 ₹5,645 43.1 34.1 0.5 43.1 24.4 UTI Healthcare Fund Growth ₹260.436
↑ 2.06 ₹1,150 42.9 38.2 -12.3 19.1 67.4 SBI Healthcare Opportunities Fund Growth ₹395.347
↓ -0.37 ₹3,522 42.2 38.2 -6 20.1 65.8 TATA India Pharma & Healthcare Fund Growth ₹27.9713
↑ 0.10 ₹1,212 40.4 36.6 -8 19.1 64.4 IDBI Small Cap Fund Growth ₹27.6884
↑ 0.47 ₹491 40 33.4 2.4 64.7 19 L&T Midcap Fund Growth ₹333.434
↑ 5.25 ₹10,753 39.7 40 1.1 30.4 19 Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 20 Feb 25
(Erstwhile Motilal Oswal MOSt Focused Midcap 30 Fund) The investment objective of the Scheme is to achieve long term capital appreciation by investing in a maximum of 30 quality mid-cap companies having long-term competitive advantages and potential for growth. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved. Motilal Oswal Midcap 30 Fund is a Equity - Mid Cap fund was launched on 24 Feb 14. It is a fund with Moderately High risk and has given a Below is the key information for Motilal Oswal Midcap 30 Fund Returns up to 1 year are on The investment objective of the scheme is to provide long term growth from a portfolio of equity / equity related instruments of companies engaged either directly or indirectly in the infrastructure sector. LIC MF Infrastructure Fund is a Equity - Sectoral fund was launched on 29 Feb 08. It is a fund with High risk and has given a Below is the key information for LIC MF Infrastructure Fund Returns up to 1 year are on (Erstwhile Motilal Oswal MOSt Focused Long Term Fund) The investment objective of the Scheme is to generate long-term capital appreciation from a diversified portfolio of predominantly equity and equity related instruments. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved. Motilal Oswal Long Term Equity Fund is a Equity - ELSS fund was launched on 21 Jan 15. It is a fund with Moderately High risk and has given a Below is the key information for Motilal Oswal Long Term Equity Fund Returns up to 1 year are on (Erstwhile Motilal Oswal MOSt Focused Multicap 35 Fund) The investment objective of the Scheme is to achieve long term capital appreciation by primarily investing in a maximum of 35 equity & equity related instruments across sectors and market-capitalization levels.However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved. Motilal Oswal Multicap 35 Fund is a Equity - Multi Cap fund was launched on 28 Apr 14. It is a fund with Moderately High risk and has given a Below is the key information for Motilal Oswal Multicap 35 Fund Returns up to 1 year are on The Scheme seeks to provide long term capital appreciation by investing in a portfolio that is predominantly constituted of equity and equity related instruments of mid cap companies. However, there can be no assurance that the funds objectives will be achieved. Invesco India Mid Cap Fund is a Equity - Mid Cap fund was launched on 19 Apr 07. It is a fund with Moderately High risk and has given a Below is the key information for Invesco India Mid Cap Fund Returns up to 1 year are on (Erstwhile UTI Pharma & Healthcare Fund) The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors. UTI Healthcare Fund is a Equity - Sectoral fund was launched on 28 Jun 99. It is a fund with High risk and has given a Below is the key information for UTI Healthcare Fund Returns up to 1 year are on (Erstwhile SBI Pharma Fund) To provide the investors maximum growth opportunity through equity
investments in stocks of growth oriented sectors of the economy. SBI Healthcare Opportunities Fund is a Equity - Sectoral fund was launched on 31 Dec 04. It is a fund with High risk and has given a Below is the key information for SBI Healthcare Opportunities Fund Returns up to 1 year are on The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns. TATA India Pharma & Healthcare Fund is a Equity - Sectoral fund was launched on 28 Dec 15. It is a fund with High risk and has given a Below is the key information for TATA India Pharma & Healthcare Fund Returns up to 1 year are on The Investment objective of the Scheme is to provide investors with the opportunities for long-term capital appreciation by investing predominantly in Equity and Equity related instruments of Small Cap companies. However
there can be no assurance that the investment objective under the Scheme will be realized. IDBI Small Cap Fund is a Equity - Small Cap fund was launched on 21 Jun 17. It is a fund with Moderately High risk and has given a Below is the key information for IDBI Small Cap Fund Returns up to 1 year are on To generate capital appreciation by investing primarily in midcap stocks. The scheme will invest primarily in companies whose market capitalization falls between the highest and the lowest constituent of the Nifty Free Float Midcap 100. L&T Midcap Fund is a Equity - Mid Cap fund was launched on 9 Aug 04. It is a fund with High risk and has given a Below is the key information for L&T Midcap Fund Returns up to 1 year are on 1. Motilal Oswal Midcap 30 Fund
CAGR/Annualized
return of 22.5% since its launch. Ranked 27 in Mid Cap
category. Return for 2024 was 57.1% , 2023 was 41.7% and 2022 was 10.7% . Motilal Oswal Midcap 30 Fund
Growth Launch Date 24 Feb 14 NAV (20 Feb 25) ₹93.2566 ↑ 0.75 (0.81 %) Net Assets (Cr) ₹24,488 on 31 Jan 25 Category Equity - Mid Cap AMC Motilal Oswal Asset Management Co. Ltd Rating ☆☆☆ Risk Moderately High Expense Ratio 0.66 Sharpe Ratio 0.93 Information Ratio 0.68 Alpha Ratio 15.2 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value Returns for Motilal Oswal Midcap 30 Fund
absolute basis
& more than 1 year are on CAGR (Compound Annual Growth Rate)
basis. as on 20 Feb 25 Duration Returns 1 Month -8% 3 Month -10.5% 6 Month -7.1% 1 Year 22.5% 3 Year 28.1% 5 Year 26.3% 10 Year 15 Year Since launch 22.5% Historical performance (Yearly) on absolute basis
Year Returns 2023 57.1% 2022 41.7% 2021 10.7% 2020 55.8% 2019 9.3% 2018 9.7% 2017 -12.7% 2016 30.8% 2015 5.2% 2014 16.5% Fund Manager information for Motilal Oswal Midcap 30 Fund
Name Since Tenure Data below for Motilal Oswal Midcap 30 Fund as on 31 Jan 25
Equity Sector Allocation
Sector Value Asset Allocation
Asset Class Value Top Securities Holdings / Portfolio
Name Holding Value Quantity 2. LIC MF Infrastructure Fund
CAGR/Annualized
return of 8.7% since its launch. Return for 2024 was 47.8% , 2023 was 44.4% and 2022 was 7.9% . LIC MF Infrastructure Fund
Growth Launch Date 29 Feb 08 NAV (20 Feb 25) ₹41.4695 ↑ 0.80 (1.98 %) Net Assets (Cr) ₹881 on 31 Jan 25 Category Equity - Sectoral AMC LIC Mutual Fund Asset Mgmt Co Ltd Rating Risk High Expense Ratio 2.3 Sharpe Ratio 0.83 Information Ratio 0.66 Alpha Ratio 16.19 Min Investment 5,000 Min SIP Investment 1,000 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value Returns for LIC MF Infrastructure Fund
absolute basis
& more than 1 year are on CAGR (Compound Annual Growth Rate)
basis. as on 20 Feb 25 Duration Returns 1 Month -14.3% 3 Month -15.6% 6 Month -19.7% 1 Year 11.5% 3 Year 23.5% 5 Year 22.3% 10 Year 15 Year Since launch 8.7% Historical performance (Yearly) on absolute basis
Year Returns 2023 47.8% 2022 44.4% 2021 7.9% 2020 46.6% 2019 -0.1% 2018 13.3% 2017 -14.6% 2016 42.2% 2015 -2.2% 2014 -6.2% Fund Manager information for LIC MF Infrastructure Fund
Name Since Tenure Data below for LIC MF Infrastructure Fund as on 31 Jan 25
Equity Sector Allocation
Sector Value Asset Allocation
Asset Class Value Top Securities Holdings / Portfolio
Name Holding Value Quantity 3. Motilal Oswal Long Term Equity Fund
CAGR/Annualized
return of 15.9% since its launch. Return for 2024 was 47.7% , 2023 was 37% and 2022 was 1.8% . Motilal Oswal Long Term Equity Fund
Growth Launch Date 21 Jan 15 NAV (20 Feb 25) ₹44.2801 ↑ 0.71 (1.63 %) Net Assets (Cr) ₹3,876 on 31 Jan 25 Category Equity - ELSS AMC Motilal Oswal Asset Management Co. Ltd Rating Risk Moderately High Expense Ratio 0.74 Sharpe Ratio 0.74 Information Ratio 0.72 Alpha Ratio 10.73 Min Investment 500 Min SIP Investment 500 Exit Load NIL Growth of 10,000 investment over the years.
Date Value Returns for Motilal Oswal Long Term Equity Fund
absolute basis
& more than 1 year are on CAGR (Compound Annual Growth Rate)
basis. as on 20 Feb 25 Duration Returns 1 Month -13.6% 3 Month -13.8% 6 Month -13.8% 1 Year 9.5% 3 Year 19.3% 5 Year 17.8% 10 Year 15 Year Since launch 15.9% Historical performance (Yearly) on absolute basis
Year Returns 2023 47.7% 2022 37% 2021 1.8% 2020 32.1% 2019 8.8% 2018 13.2% 2017 -8.7% 2016 44% 2015 12.5% 2014 Fund Manager information for Motilal Oswal Long Term Equity Fund
Name Since Tenure Data below for Motilal Oswal Long Term Equity Fund as on 31 Jan 25
Equity Sector Allocation
Sector Value Asset Allocation
Asset Class Value Top Securities Holdings / Portfolio
Name Holding Value Quantity 4. Motilal Oswal Multicap 35 Fund
CAGR/Annualized
return of 17.1% since its launch. Ranked 5 in Multi Cap
category. Return for 2024 was 45.7% , 2023 was 31% and 2022 was -3% . Motilal Oswal Multicap 35 Fund
Growth Launch Date 28 Apr 14 NAV (20 Feb 25) ₹55.388 ↑ 0.52 (0.94 %) Net Assets (Cr) ₹11,855 on 31 Jan 25 Category Equity - Multi Cap AMC Motilal Oswal Asset Management Co. Ltd Rating ☆☆☆☆☆ Risk Moderately High Expense Ratio 0.94 Sharpe Ratio 0.9 Information Ratio 0.49 Alpha Ratio 13.01 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value Returns for Motilal Oswal Multicap 35 Fund
absolute basis
& more than 1 year are on CAGR (Compound Annual Growth Rate)
basis. as on 20 Feb 25 Duration Returns 1 Month -5.9% 3 Month -6.9% 6 Month -3.8% 1 Year 19.3% 3 Year 19% 5 Year 14.9% 10 Year 15 Year Since launch 17.1% Historical performance (Yearly) on absolute basis
Year Returns 2023 45.7% 2022 31% 2021 -3% 2020 15.3% 2019 10.3% 2018 7.9% 2017 -7.8% 2016 43.1% 2015 8.5% 2014 14.6% Fund Manager information for Motilal Oswal Multicap 35 Fund
Name Since Tenure Data below for Motilal Oswal Multicap 35 Fund as on 31 Jan 25
Equity Sector Allocation
Sector Value Asset Allocation
Asset Class Value Top Securities Holdings / Portfolio
Name Holding Value Quantity 5. Invesco India Mid Cap Fund
CAGR/Annualized
return of 16.4% since its launch. Ranked 38 in Mid Cap
category. Return for 2024 was 43.1% , 2023 was 34.1% and 2022 was 0.5% . Invesco India Mid Cap Fund
Growth Launch Date 19 Apr 07 NAV (20 Feb 25) ₹149.7 ↑ 2.29 (1.55 %) Net Assets (Cr) ₹5,645 on 31 Jan 25 Category Equity - Mid Cap AMC Invesco Asset Management (India) Private Ltd Rating ☆☆ Risk Moderately High Expense Ratio 1.89 Sharpe Ratio 0.82 Information Ratio 0 Alpha Ratio 0 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value Returns for Invesco India Mid Cap Fund
absolute basis
& more than 1 year are on CAGR (Compound Annual Growth Rate)
basis. as on 20 Feb 25 Duration Returns 1 Month -7.4% 3 Month -7% 6 Month -6.2% 1 Year 16.2% 3 Year 21.1% 5 Year 22.1% 10 Year 15 Year Since launch 16.4% Historical performance (Yearly) on absolute basis
Year Returns 2023 43.1% 2022 34.1% 2021 0.5% 2020 43.1% 2019 24.4% 2018 3.8% 2017 -5.3% 2016 44.3% 2015 1.1% 2014 6.4% Fund Manager information for Invesco India Mid Cap Fund
Name Since Tenure Data below for Invesco India Mid Cap Fund as on 31 Jan 25
Equity Sector Allocation
Sector Value Asset Allocation
Asset Class Value Top Securities Holdings / Portfolio
Name Holding Value Quantity 6. UTI Healthcare Fund
CAGR/Annualized
return of 14.8% since its launch. Ranked 40 in Sectoral
category. Return for 2024 was 42.9% , 2023 was 38.2% and 2022 was -12.3% . UTI Healthcare Fund
Growth Launch Date 28 Jun 99 NAV (20 Feb 25) ₹260.436 ↑ 2.06 (0.80 %) Net Assets (Cr) ₹1,150 on 31 Jan 25 Category Equity - Sectoral AMC UTI Asset Management Company Ltd Rating ☆ Risk High Expense Ratio 2.38 Sharpe Ratio 1.03 Information Ratio -0.36 Alpha Ratio 0.34 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value Returns for UTI Healthcare Fund
absolute basis
& more than 1 year are on CAGR (Compound Annual Growth Rate)
basis. as on 20 Feb 25 Duration Returns 1 Month -7.1% 3 Month -6.4% 6 Month -3.7% 1 Year 14.8% 3 Year 19.2% 5 Year 23.2% 10 Year 15 Year Since launch 14.8% Historical performance (Yearly) on absolute basis
Year Returns 2023 42.9% 2022 38.2% 2021 -12.3% 2020 19.1% 2019 67.4% 2018 1.2% 2017 -7.5% 2016 6.2% 2015 -9.7% 2014 12.4% Fund Manager information for UTI Healthcare Fund
Name Since Tenure Data below for UTI Healthcare Fund as on 31 Jan 25
Equity Sector Allocation
Sector Value Asset Allocation
Asset Class Value Top Securities Holdings / Portfolio
Name Holding Value Quantity 7. SBI Healthcare Opportunities Fund
CAGR/Annualized
return of 15.4% since its launch. Ranked 34 in Sectoral
category. Return for 2024 was 42.2% , 2023 was 38.2% and 2022 was -6% . SBI Healthcare Opportunities Fund
Growth Launch Date 31 Dec 04 NAV (19 Feb 25) ₹395.347 ↓ -0.37 (-0.09 %) Net Assets (Cr) ₹3,522 on 31 Jan 25 Category Equity - Sectoral AMC SBI Funds Management Private Limited Rating ☆☆ Risk High Expense Ratio 2.09 Sharpe Ratio 1.36 Information Ratio 0.67 Alpha Ratio 4.66 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-15 Days (0.5%),15 Days and above(NIL) Growth of 10,000 investment over the years.
Date Value Returns for SBI Healthcare Opportunities Fund
absolute basis
& more than 1 year are on CAGR (Compound Annual Growth Rate)
basis. as on 20 Feb 25 Duration Returns 1 Month -5% 3 Month -4.1% 6 Month 0.6% 1 Year 13.8% 3 Year 22.4% 5 Year 24.5% 10 Year 15 Year Since launch 15.4% Historical performance (Yearly) on absolute basis
Year Returns 2023 42.2% 2022 38.2% 2021 -6% 2020 20.1% 2019 65.8% 2018 -0.5% 2017 -9.9% 2016 2.1% 2015 -14% 2014 27.1% Fund Manager information for SBI Healthcare Opportunities Fund
Name Since Tenure Data below for SBI Healthcare Opportunities Fund as on 31 Jan 25
Equity Sector Allocation
Sector Value Asset Allocation
Asset Class Value Top Securities Holdings / Portfolio
Name Holding Value Quantity 8. TATA India Pharma & Healthcare Fund
CAGR/Annualized
return of 11.9% since its launch. Return for 2024 was 40.4% , 2023 was 36.6% and 2022 was -8% . TATA India Pharma & Healthcare Fund
Growth Launch Date 28 Dec 15 NAV (20 Feb 25) ₹27.9713 ↑ 0.10 (0.37 %) Net Assets (Cr) ₹1,212 on 31 Jan 25 Category Equity - Sectoral AMC Tata Asset Management Limited Rating Risk High Expense Ratio 0 Sharpe Ratio 0.9 Information Ratio 0.56 Alpha Ratio 2.72 Min Investment 5,000 Min SIP Investment 150 Exit Load 0-3 Months (0.25%),3 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value Returns for TATA India Pharma & Healthcare Fund
absolute basis
& more than 1 year are on CAGR (Compound Annual Growth Rate)
basis. as on 20 Feb 25 Duration Returns 1 Month -7.4% 3 Month -5.1% 6 Month -6.6% 1 Year 10.7% 3 Year 19% 5 Year 22.5% 10 Year 15 Year Since launch 11.9% Historical performance (Yearly) on absolute basis
Year Returns 2023 40.4% 2022 36.6% 2021 -8% 2020 19.1% 2019 64.4% 2018 5.5% 2017 -2.6% 2016 4.7% 2015 -14.7% 2014 Fund Manager information for TATA India Pharma & Healthcare Fund
Name Since Tenure Data below for TATA India Pharma & Healthcare Fund as on 31 Jan 25
Equity Sector Allocation
Sector Value Asset Allocation
Asset Class Value Top Securities Holdings / Portfolio
Name Holding Value Quantity 9. IDBI Small Cap Fund
CAGR/Annualized
return of 14.2% since its launch. Return for 2024 was 40% , 2023 was 33.4% and 2022 was 2.4% . IDBI Small Cap Fund
Growth Launch Date 21 Jun 17 NAV (20 Feb 25) ₹27.6884 ↑ 0.47 (1.72 %) Net Assets (Cr) ₹491 on 31 Jan 25 Category Equity - Small Cap AMC IDBI Asset Management Limited Rating Risk Moderately High Expense Ratio 2.3 Sharpe Ratio 0.61 Information Ratio 0.24 Alpha Ratio 11.34 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-12 Months (1%),12 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value Returns for IDBI Small Cap Fund
absolute basis
& more than 1 year are on CAGR (Compound Annual Growth Rate)
basis. as on 20 Feb 25 Duration Returns 1 Month -15% 3 Month -13% 6 Month -15.3% 1 Year 6.5% 3 Year 17.3% 5 Year 23.7% 10 Year 15 Year Since launch 14.2% Historical performance (Yearly) on absolute basis
Year Returns 2023 40% 2022 33.4% 2021 2.4% 2020 64.7% 2019 19% 2018 -4.4% 2017 -15% 2016 2015 2014 Fund Manager information for IDBI Small Cap Fund
Name Since Tenure Data below for IDBI Small Cap Fund as on 31 Jan 25
Equity Sector Allocation
Sector Value Asset Allocation
Asset Class Value Top Securities Holdings / Portfolio
Name Holding Value Quantity 10. L&T Midcap Fund
CAGR/Annualized
return of 18.6% since its launch. Ranked 5 in Mid Cap
category. Return for 2024 was 39.7% , 2023 was 40% and 2022 was 1.1% . L&T Midcap Fund
Growth Launch Date 9 Aug 04 NAV (20 Feb 25) ₹333.434 ↑ 5.25 (1.60 %) Net Assets (Cr) ₹10,753 on 31 Jan 25 Category Equity - Mid Cap AMC L&T Investment Management Ltd Rating ☆☆☆☆ Risk High Expense Ratio 1.77 Sharpe Ratio 0.53 Information Ratio -0.14 Alpha Ratio 4.43 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value Returns for L&T Midcap Fund
absolute basis
& more than 1 year are on CAGR (Compound Annual Growth Rate)
basis. as on 20 Feb 25 Duration Returns 1 Month -11.2% 3 Month -12.1% 6 Month -14.1% 1 Year 6% 3 Year 19.1% 5 Year 18.5% 10 Year 15 Year Since launch 18.6% Historical performance (Yearly) on absolute basis
Year Returns 2023 39.7% 2022 40% 2021 1.1% 2020 30.4% 2019 19% 2018 -0.2% 2017 -12% 2016 52.3% 2015 9.8% 2014 10.8% Fund Manager information for L&T Midcap Fund
Name Since Tenure Data below for L&T Midcap Fund as on 31 Jan 25
Equity Sector Allocation
Sector Value Asset Allocation
Asset Class Value Top Securities Holdings / Portfolio
Name Holding Value Quantity